This study aimed to determine the prevalence of low bone mass and assess its relationship with abnormal bone turnover among HIV-infected Asian adolescents.
Introduction
Significant success in expanding access to effective combination antiretroviral therapy (cART) has turned HIV infection into a chronic life-long illness. Perinatally infected infants and children now survive into adolescence and young adulthood similarly to their healthy peers [1] . However, long-term, non-AIDS-related complications associated with HIV infection and cART have been emerging [1] [2] [3] . Adverse bone health is a specific concern in this population undergoing normal physical development [3] [4] [5] . Low bone mass, evaluated by dualenergy X-ray absorptiometry (DXA), has been reported in HIV-infected children and adolescents [6] [7] [8] [9] [10] . The prevalence of low bone mass, defined as bone mineral density (BMD) Z-score ≤ À2.0, has been observed to be higher in middle-income (17-32%) [6] [7] [8] compared with highincome countries (4-8%) [9, 10] . Importantly, bone mass in this population has appeared to be much lower than in their age-and sex-matched HIV-exposed but uninfected counterparts [9] , and in healthy controls [11] [12] [13] .
There are multiple factors associated with decreased bone mass in HIV-infected individuals [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . Hypovitaminosis D, inadequate calcium intake, limited physical activity, corticosteroid use, low lean body mass, short stature and delayed puberty are among the important traditional risk factors [7, [9] [10] [11] [12] . In addition, HIV-specific factors, including HIV itself, advanced HIV disease, impaired immunological and virological status, and specific antiretroviral drugs are the major determinants accelerating bone demineralization [6] [7] [8] [9] [10] [13] [14] [15] [16] [17] [18] [19] [20] .
Because bone is a dynamic tissue, it continuously undergoes remodelling, which consists of bone resorption (mediated by osteoclasts) and formation (mediated by osteoblasts) throughout life to maintain its strength and mineral homeostasis [21, 22] . Uncoupling between these two processes can result in increased bone turnover, a net decline in bone mass, and the development of bone disorders [22] .
As a great deal of bone mineral accrual occurs during childhood and adolescence and approximately 90% of final adult bone mass is attained by 18 years of age [23] , the impairment of bone mineralization during these critical periods can contribute to serious consequences, particularly osteoporosis and bone fracture, later in life [24, 25] . However, information on the extent of bone demineralization and its pathogenesis is limited in resource-constrained settings. This study aimed to determine the prevalence of and important factors associated with low bone mass, as well as its relationship with abnormal bone turnover among perinatally HIV-infected Asian adolescents.
Methods

Study design and participants
This multicentre, cross-sectional study was conducted in four clinical research sites in Asia: three in Thailand [HIV Netherland Australia Thailand, Bangkok; the Faculty of Medicine and Research Institute for Health Sciences (RIHES), Chiang Mai; Srinagarind Hospital, Khon Kaen University, Khon Kaen], and one in Indonesia (Cipto Mangunkusumo General Hospital, Jakarta). Eligible participants were perinatally HIV-infected adolescents aged 10-18 years who were on ART and had a documented history of virological suppression (HIV RNA < 400 copies/mL) within the past 6 months. Participants were excluded if they had underlying bone disease or established risks factors for adverse bone health, such as renal failure or endocrine diseases, or received medications for treatment of bone demineralization or other medications that affect bone health (e.g. corticosteroids). The study was approved by the institutional review boards at all research sites. All participants and their caregivers provided written informed consent and assent, as appropriate, before taking part in this study.
Data collection and clinical assessments
Clinical data for HIV-specific characteristics were abstracted from medical records. Physical examination, anthropometric measurement and Tanner stage evaluation were conducted. Data on physical activity levels, sun exposure duration and daily dietary intake were obtained by interview using standard questionnaires.
Weight and height measurements were converted into age-and sex-standardized Z-scores, using a Thai normative reference [26] . Body mass index (BMI) was calculated, and transformed into BMI percentile based on the US Centers for Disease Control and Prevention (CDC) reference [27] . Physical activity levels were assessed and reported as physical activity scores, ranging from 1 (low) to 5 (high) [28] . The average duration of sun exposure (hours/day) was calculated. Daily calories (kcal/day) and calcium (mg/day) intake were analysed using the Institute of Nutrition, Mahidol University Calculation (INMUCAL)-Nutrients Program, version 3.0 (Institute of Nutrition, Mahidol University, Bangkok, Thailand) [29] .
Blood sample collection and laboratory analysis
At enrolment, fasting blood samples for determination of calcium, phosphorus, 25-hydroxyvitamin D (25-OHD), intact parathyroid hormone (iPTH) and bone turnover markers were collected. Phlebotomy was performed between 8:00-10:00 am to avoid diurnal variation in bone turnover markers. Blood tubes were centrifuged to obtained serum which was stored at À70°C until laboratory analysis.
The concentrations of 25-OHD, iPTH, and bone turnover markers which included C-terminal cross-linked telopeptide of type I collagen (CTX; a bone resorption marker) and procollagen type I amino-terminal propeptide (PINP; a bone formation marker) were determined using an automated electrochemiluminescence immunoassay (ECLIA) (Roche Diagnostics, Mannheim, Germany) on a Cobas â e411 immunoassay analyzer (Roche Diagnostics, Mannheim, Germany). Blood specimens for these laboratory measurements were analysed by a single technician at a single reference site at RIHES, Chiang Mai University (Chiang Mai, Thailand). The other laboratory measurements were conducted locally using routine laboratory analyses. The normal level of 25-OHD was ≥ 30 ng/mL [30] , and the lower and upper limits of normal for iPTH were 10 and 65 pg/mL, respectively [31] . The normal range of calcium was 8.4-10.2 mg/dL, and phosphorus ranges were 3.3-5.4 mg/dL (age 10-15 years) and 2.4-4.4 mg/dL (age > 15 years). The normal ranges for alkaline phosphatase were 100-390 U/L (male) and 100-320 U/L (female).
Bone health evaluations
Lumbar spine (L2ÀL4) bone mass was evaluated by the DXA technique using scanners from the same manufacturer [Lunar, General Electric (GE) Healthcare, Madison, WI, USA] at all sites. The machines were calibrated on a daily basis following the standard quality assurance procedures provided by the manufacturer. Additionally, a spine quality control phantom was scanned weekly to monitor the performance of a scanner over time. The scans were analysed using enCORE software version 14.1 (enCORE; GE Healthcare, Madison, WI, USA).
Lumbar spine bone mass measurements were reported as BMD Z-scores, which standardizes the absolute BMD results against the average results expected for a Thai adolescent of similar age and sex [32] . Additionally, bone mineral apparent density (BMAD) was calculated using the formula BMAD (g/cm 3 ) = BMD (g/cm 2 ) 9 [4/( ¶9 width of lumbar spine measurement area)] to eliminate the effects of height and skeletal size on bone mass measurement. The BMAD Z-score was also computed based on a Thai normative reference [32] . According to the 2013 Pediatric Official Positions of International Society for Clinical Densitometry (ISCD), lumbar spine BMD and BMAD Z-scores ≤ À2 were defined as low bone mass [33] .
Sample size and power
In previous studies conducted in middle-income countries, the prevalence of low bone mass (BMD Zscore ≤ À2) among perinatally HIV-infected adolescents varied from 23.8 to 32.4% [7, 8] . We had hypothesized that the prevalence among our adolescents would be 30%. Therefore, to have a study that had 80% power with a two-sided significance level of 0.05, we needed to enroll approximately 390 adolescents.
Statistical analysis
Characteristics and laboratory results for adolescents with BMD Z-scores ≤ À2 and > À2 were compared using chisquare and Wilcoxon rank sum tests for categorical and continuous variables, respectively. The bone mass of HIVinfected individuals was compared with that of age-and sex-matched healthy peers, using the Student t-test. Univariable linear regression analyses were performed to identify factors associated with BMD and BMAD Z-scores.
Covariates were retained in a multivariable model if they were associated with Z-scores with a P < 0.1 in univariable analysis. Variables suspected to be potential effect modifiers of the associations were assessed. The magnitudes of association were summarized with mean difference and adjusted mean difference, together with their 95% confidence intervals (CIs), in univariable and multivariable analyses, respectively. In the models determining the association between bone turnover and bone mass, bone biochemical markers (CTX and PINP) were adjusted by significant factors in multivariable analysis. Each marker was transformed into its natural logarithm in order to allow the data to fit a standard normal distribution. The results of analyses on logtransformed variables were back-transformed and then interpreted on the original scale. The magnitudes of association were reported as mean differences and adjusted mean differences per 10% increase in bone biomarker levels.
A two-sided P < 0.05 was considered to indicate statistical significance. All statistical analyses were performed using Stata statistical software, version 13. (StataCorp LP, College Station, TX, USA).
Results
Participant characteristics
Between April and December 2014, 396 perinatally HIVinfected adolescents were enrolled in the study, of whom approximately half (57%) were female. The median age was 15.0 years, and 73% were in Tanner stage 3À5. Prior to ART initiation, 167 adolescents (43.7%) were in World Health Organization (WHO) clinical stage 3À4, with a median CD4 T-cell percentage of 12.8%. At enrolment, two-thirds were taking nonnucleoside reverse transcriptase inhibitor-based treatment, and one-third, protease inhibitor (PI)-based treatment, with a median duration of ART use of 9.3 years and a median CD4 T-cell count of 734 cells/lL (Table 1 ). All had HIV RNA < 400 copies/mL and 96% had HIV RNA <50 copies/mL.
Laboratory results and bone turnover markers
The median serum 25-OHD level was 26.3 ng/mL, and the median iPTH level was 41.7 pg/mL. The median serum calcium level was 9.5 mg/dL. For bone turnover markers, the median CTX and PINP levels were 1270 ng/ L and 337 lg/L, respectively. The other laboratory results are shown in Table 2 .
Lumbar spine bone mass of HIV-infected adolescents
Of 396 adolescents, 65 had lumbar spine BMD Zscores ≤ À2, representing a prevalence of low bone mass of 16.4% (95% CI 12.7-20.0%). Thirty-three adolescents had lumbar spine BMAD Z-scores ≤ À2, which reflects a prevalence of 8.3% (95% CI 5.6-11.1%). The mean BMD of HIV-infected adolescents was 0.899 [standard deviation (SD) 0.170] g/cm 2 , which was significantly lower than that of age-and sex-matched HIV-uninfected 
The comparison of lumbar spine bone mass between HIV-infected and healthy adolescents stratified by sex is shown in Figure 1 .
Factors associated with low bone mass
In the multivariable analysis for BMD, older age, BMI <5th percentile, boosted PI exposure and CD4 T-cell percentage < 15% prior to ART initiation were significantly associated with lower BMD Z-score (Table 3 ). In the multivariable analysis for BMAD, in addition to the above, female sex was also an independent factor associated with lower BMAD Z-score (Table 3) .
Association between bone turnover and bone mass
In the multivariable analysis for BMD, PINP was inversely associated with BMD Z-score, while CTX showed a trend for a negative association that did not reach statistical significance. In the multivariable analysis for BMAD, PINP and CTX were negatively associated with BMAD Z-score (Table 4) .
Discussion
Sixteen percent of our perinatally HIV-infected Asian adolescents had evidence of adverse bone health, defined as having lumbar spine BMD Z-scores ≤ À2. Bone mass for these individuals was much lower than that of their age-and sex-matched healthy peers. Older age, female sex, low BMI, boosted PI exposure, and low CD4 T-cell percentage prior to ART initiation were associated with decreased bone mass. The dysregulation of bone turnover, demonstrated by increased bone formation and resorption markers, correlated with low bone mass. The 16.4% prevalence of low bone mass (lumbar spine BMD Z-score ≤ À2) among our Asian adolescents was comparable to that observed in middle-income countries (17-32% in Brazil) [6, 8] , but much higher than those documented in resource-rich countries (4% in the USA and 8% in the Netherlands) [9, 10] . This may be because age, anthropometric parameters and HIV disease status were more similar in our and the Brazilian participants [6, 8] , compared with the US and Dutch participants, who were younger, had better nutritional status and less severe HIV disease [9, 10] . These key demographic, growth and HIV disease parameters probably contributed to differences in the prevalence of low bone mass in resource-rich vs. limited settings.
As recommended by the ISCD, BMD results for children and adolescents can be affected by chronic diseases, including HIV/AIDS, which lead to short stature or delayed sexual maturation. Therefore, BMAD may be a preferred endpoint in those infected by HIV, as it is adjusted for height, bone size and skeletal dimension [33] . In this study, we calculated the BMAD Z-score based on a Thai normative age-and sex-matched reference [32] , and found that the prevalence of low bone mass (lumbar spine BMAD Z-score ≤ À2) declined to 8.3%. Because about one-fourth of our adolescents were short-for-age [height-for-age Z-score (HAZ) < À1.5] as they had delayed ART initiation, resulting in advanced HIV disease, using the BMAD Z-score to determine the prevalence of low bone mass might be more appropriate than using the BMD Z-score, and this made our prevalence comparable to those documented in resource-rich countries. Additionally, the ISCD recommends employing HAZ adjustment to remove the confounding effect of height on bone density measurement [33] . This rationale has been supported by Zemel et al. [34] , who found that the HAZ adjustment is the least biased method compared with other approaches. Unfortunately, this study could not assess the HAZ-adjusted BMD Z-score because there are no normative Asian reference data. Moreover, the publicly available web-based analysis tool is developed for US children based on BMD measured using the Hologic DXA system (Hologic, Inc., Bedford, MA, USA) which is different from ours.
In this study, we found that HIV-specific factors, including boosted PI exposure and low CD4 T-cell percentage prior to ART initiation, and traditional risk factors, including older age, female sex and low BMI (a combination of weight and height), were associated with lower bone mass. PI-based regimens have been reported as risk factors for reduced bone mass in children and youth infected with HIV in several studies [6, 10, 13] . However, the mechanism of bone mass deterioration caused by PI is still unclear. A previous in vitro study found that lopinavir significantly inhibited osteoblast activity, whereas ritonavir enhanced osteoclast activity significantly [35] . In addition, several studies demonstrated that delayed linear growth and poor weight gain were independently associated with compromised bone mass in HIV-infected adolescents [7] [8] [9] 12] . We used a ) of HIV-infected male adolescents with that of healthy male adolescents; and (d) comparison of BMAD of HIV-infected female adolescents with that of healthy female adolescents. Data for healthy adolescents are from Nakavachara et al. [32] .
Thai normative reference to calculate height-for-age and weight-for-age Z-scores for all participants in this study, but as anthropometric parameters for Thai and Indonesian adolescents were comparable, this would not impact our results [26, 36] . Because there were no Asian norms for BMI, our use of the US CDC reference to compute BMI percentile might have inflated the number of adolescents who had low BMI (BMI <5th percentile) and magnified its association with decreased bone mass.
Disturbance of the bone turnover process can lead to a net reduction in bone mass [37] . In this study, we observed that high bone turnover, reflected in increased levels of bone biomarkers, correlated with reduced bone mass, suggesting that dysregulation of bone turnover was accelerating bone loss in this population.
To the best of our knowledge, this is the largest cohort study evaluating bone health status among perinatally HIV-infected adolescents in resource-limited settings. Other strengths of our study include the use of calculated BMAD and BMAD Z-scores as endpoints that we believe to be a more accurate assessment of bone mass in adolescents with HIV infection than the BMD and BMD Zscores. We were able to use DXA scanners from the same manufacturer (Lunar-GE) for all participating sites. We also performed the measurements of bone metabolismrelated markers and bone turnover markers at a single central laboratory. Our study is limited by its cross-sectional design. Additionally, our bone densitometry was performed on the lumbar spine, which is mostly trabecular bone; therefore, the results may not be applicable to BMD, bone mineral density; BMAD, bone mineral apparent density; CI, confidence interval; CTX, C-terminal cross-linked telopeptide of type I collagen (bone resorption marker); PINP, procollagen type I amino-terminal propeptide (bone formation marker). *The multivariable model was adjusted for age, body mass index (BMI), history of receiving boosted protease inhibitors and CD4 T-cell percentage prior to antiretroviral therapy (ART).
other parts of the body, particularly the hip or proximal femur, which are mostly cortical bone. Performing total body bone densitometry may have overcome this limitation, but it would have been very costly, and, importantly, exposed these young people to greater amounts of radiation. Furthermore, because we compared bone mass of our adolescents to that of age-and sex-matched healthy peers, regardless of pubertal stage, our prevalence of low bone mass may have been potentially overestimated, as HIV-infected individuals possibly have delayed pubertal development. Finally, we had to use Thai norms for Indonesian adolescents because of a lack of Indonesian norms, but they constituted a small proportion (6%) of the participants.
In conclusion, adverse bone health affects about 10% of Asian children and adolescents perinatally infected with HIV. Individuals with older age, female sex, low BMI, boosted PI exposure, and poor immunological status before ART initiation were at higher risk of low bone mass despite effective treatment. Dysregulation of bone turnover was associated with bone demineralization. Prospective research would be needed to monitor for long-term consequences of bone mass deterioration, particularly bone fracture, which may occur in the fourth to fifth decades of life. Furthermore, screening for low bone mass should be implemented to identify at-risk young people with HIV infection who might benefit from interventions to promote long-term bone health.
